Migraine Management Today - How to Make It Personalized

Migraine is among the most prevalent neurological disorders globally and a major cause of disability. As scientific understanding and therapeutic options evolve, clinicians increasingly recognize the need for personalized migraine management. Migraine is no longer approached as a uniform condition—patients differ in frequency, phenotype, comorbidities, triggers, hormonal influences, and response to therapy. Personalized care aims to match the right treatment to the right patient at the right time.

This CME activity reviews modern approaches to tailoring migraine treatment. Participants will explore how to identify migraine progression, why some patients transition from episodic to chronic migraine, and what factors—behavioral, environmental, biologic, and pharmacologic—contribute to worsening disease burden. The session emphasizes early identification of transformation risks, individualized selection of acute and preventive therapies, and strategies to minimize disability while improving quality of life.

Learners will review current therapeutic options, including triptans, gepants, ditans, neuromodulation, CGRP monoclonal antibodies, and onabotulinumtoxinA, as well as lifestyle modification and comorbidity management. By integrating clinical insights with a precision-medicine approach, this course equips clinicians to deliver effective, individualized care to migraine patients.

Educational Objectives

After completing this activity, learners will be able to:

• Recognize clinical patterns that indicate the progression of migraine.
• Identify biological, behavioral, and environmental factors associated with migraine progression.
• Differentiate between acute and preventive migraine treatment options based on patient characteristics.
• Select personalized, evidence-based treatment strategies for acute and preventive migraine management.

Who Should Do This Course?

• Clinicians managing patients with episodic or chronic migraine seeking to personalize treatment plans.
• Healthcare providers evaluating patients for migraine progression or transformation.
• Practitioners selecting and optimizing acute and preventive therapies, including CGRP-pathway treatments.
• Women’s health providers managing hormonally influenced migraine patterns.
• Clinicians addressing comorbidities (anxiety, depression, obesity, sleep disorders) that significantly impact migraine outcomes.

Did You Know?

• More than 1 billion people worldwide live with migraine—making it the second leading cause of disability globally.
• Women experience migraine three times more often than men due to hormonal fluctuations across reproductive years.
• Approximately 8% of episodic migraine patients convert to chronic migraine annually, often influenced by modifiable risk factors.
• Medication overuse headache affects up to half of chronic migraine patients.
• Preventive treatments such as CGRP monoclonal antibodies and gepants have transformed modern migraine management with improved tolerability.
• Anxiety and depression are twice as common in migraine patients, highlighting the importance of a holistic care approach.

The estimated time to complete this activity is 0.75 hour.